A study of KIR genes and HLA-C in Vogt-Koyanagi-Harada disease in Saudi Arabia

Molecular Vision

Volumn 17, Issue , 2011, Pages 3523-3528

  Sheereen, Atia ^a   Gaafar, Ameera ^a   Iqneibi, Alia ^a   Eldali, Abdelmoneim ^a   Tabbara, Khalid F ^a,b,c   Adra, Chaker ^a,d   Al Hussein, Khaled ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b The Eye Foundation for Research in Ophthalmology   (Saudi Arabia)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3;

ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA BINDING; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; INCIDENCE; KIR GENE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SAUDI ARABIA; VOGT KOYANAGI SYNDROME;

ALLELES; CASE-CONTROL STUDIES; COHORT STUDIES; EYE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-C ANTIGENS; HOMOZYGOTE; HUMANS; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; RECEPTORS, KIR; SAUDI ARABIA; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 84856183367     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Norose K, Yano A. Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanangi-Harada disease. Br J Ophthalmol 1996; 80:1002-8. [PMID: 8976730]
2. Sugita S, Takase H, Taguchi C, Imai Y, Kamoi K, Kawaguchi T, Sugamoto Y, Futagami Y, Itoh K, Mochizuki M. Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens. Invest Ophthalmol Vis Sci 2006; 47:2547-54. [PMID: 16723469]
3. Kim MH, Seong MC, Kwak NH, Yoo JS, Huh W, Kim TG, Han H. Association of HLA with Vogt-Koyanagi-Harada syndrome in Koreans. Am J Ophthalmol 2000; 129:173-7. [PMID: 10682969]
4. Shindo Y, Ohno S, Yamamoto T, Nakamura S, Inoko H. Complete association of the HLA-DRB1*04 and-DQB1*04 alleles with Vogt-Koyanagi-Harada's disease. Hum Immunol 1994; 39:169-76. [PMID: 8026985]
5. Iqniebi A, Gaafar A, Sheereen A, Al Sulaiman A, Mohammed G, Al Hussein K, Tabbara KF. HLA-DRB1 among patients with Vogt-Koyanangi-Harada disease in Saudi Arabia. Mol Vis 2009; 15:1876-80. [PMID: 19756183]
6. Levinson RD, See RF, Rajalingam R, Reed EF, Park MS, Rao NA, Holland GN. HLA-DRB1 and-DQB1 alleles in mestizo patients with Vogt-Koyanangi-Harada's disease in Southern California. Hum Immunol 2004; 65:1477-82. [PMID: 15603876]
7. Gaudieri S, De Santis, Mckinnon E, Moore C, Nolan D, Witt CS, Mallal SA, Christiansen FT. Killer immunoglobulin-like receptors and HLA-act both independently and synergistically to modify HIV disease progression. Genes Immun 2005; 6:683-90. [PMID: 16121209]
8. López-Vázquez A, Miña-Blanco A, Martínez-Borra J, Njobvu PD, Suárez-Alvarez B, Blanco-Gelaz MA, González S, Rodrigo L, López-Larrea C. Interaction between KIR3DL1 and HLA-B*57 supertype alleles influence the progression of HIV-1 infection in a Zambian population. Hum Immunol 2005; 66:285-9. [PMID: 15784466]
9. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J, Cheng J, Goedert JJ, Vlahov D, Hilgartner M, Cox S, Little AM, Alexander GJ, Cramp ME, O'Brien SJ, Rosenberg WM, Thomas DL, Carrington M. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004; 305:872-4. [PMID: 15297676]
10. Méndez A, Granda H, Meenagh A, Contreras S, Zavaleta R, Mendoza MF, Lzquierdo L, Sarmiento ME, Acosta A, Middleton D. Study of KIR genes in tuberculosis patients. Tissue Antigens 2006; 68:386-9. [PMID: 17092251]
11. Franceschi DSA, Mazini PS, Rudnick CCC, Sell AM, Tsuneto LT, De Melo FC, Braga MA, Peixoto PRF, Visentainer JEL. Association between KIR genotypes and Leprosy in Brazil. Tissue Antigens 2008; 72:478-82. [PMID: 18778326]
12. Levinson RD, Du Z, Luo L, Monnet D, Tabbary T, Brezin AP, Zhao L, Gjertson DW, Holland GN, Reed EE, Cohen JHE, Rajalingam R. Combination of KIR and HLA gene variants auguments the risk of developing birdshot chorioretinopathy in HLA-A*29 positive individuals. Genes Immun 2008; 9:249-58. [PMID: 18340360]
13. Boyton RJ, Smith J, Ward R, Jones M, Ozerovitch L, Wilson R, Rose M, Trowsdale J. HLA-C and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis. Am J Respir Crit Care Med 2006; 173:327-33. [PMID: 16254274]
14. van der Slik AR, Koeleman BP, Verduijn W, Bruining GJ, Roep BO, Giphart MJ. KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 2003; 52:2639-42. [PMID: 14514651]
15. Middleton D, Halfpenny I, Meenagh A, Williams F, Sivula J. Tuomilehto-Wolf E. Investigation of KIR gene frequencies in type I diabetes mellitus. Hum Immunol 2006; 67:986-90. [PMID: 17174747]
16. Pellett F, Siannis F, Vukin I, Lee P, Urowitz MB, Gladmann DD. KIRs and autoimmune disease: studies in systemic lupus erythematosus and scleroderma. Tissue Antigens 2007; 69:106-8. [PMID: 17445179]
17. Momot T, Koch S, Hunzelmann N, Kreig T, Ulbricht K, Schmidt RE, Witt T. Association of killer cell immunoglobulin-like receptors with Scleroderma. Arthritis Rheum 2004; 50:1561-5. [PMID: 15146426]
18. Lowe DP, Cook MA, Simon JB, Briggs DC, Sjogren UK. Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome. Rheumatology 2009; 48:359-62. [PMID: 19181658]
19. Jiao YL, Zhang BC, You L, Li JF, Zhang J, Ma CY, Cui B, Wang LC, Chen ZJ, Zhao YR. Polymorphisms of KIR gene and HLA-C alleles: Possible Association with Susceptibility to HLA-B-27-Positive patients with Ankylosing spondilitis. J Clin Immunol 2010; 30:840-4. [PMID: 20652381]
20. Lanier LL. NK cell Recognition. Annu Rev Immunol 2005; 23:225-74. [PMID: 15771571]
21. Vilches C, Parham P. KIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity. Annu Rev Immunol 2002; 20:217-51. [PMID: 11861603]
22. Rajalingam R. Killer Cell Immunoglobulin-like Receptor Influence the Innate and Adaptive Immune Responses. Iran J Immunol 2007; 4:61-78. [PMID: 17652846]
23. Stewart CA, Laugier AF, Vely F, Saulquin X, Reidmuller J, Tisserant A, Gauthier L, Romagne F, Ferracci G, Arosa FA, Moretta A, Sun PD, Ugolini S, Vivier E. Recognition of peptide-MHC class I complexes by activating Killer immunoglobulin-like receptors. Proc Natl Acad Sci USA 2005; 102:13224-9. [PMID: 16141329]
24. Snyder MR, Nakajima NT, Leibson PJ, Weyand CM, Goronzy JJ. Stimulatory killer Ig-like receptors modulate T cell activation through DAP-12-dependent and DAP-12-independent mechanisms. J Immunol 2004; 173:3725-31. [PMID: 15356118]
25. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J, Cheng J, Goedert JJ, Vlahov D, Hilgartner M, Cox S, Little AM, Alexander GJ, Cramp ME, O'Brien SJ, Rosenberg WM, Thomas DL, Carrington M. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004; 305:872-4. [PMID: 15297676]
26. Boyton RJ, Attmann DM. Natural killer cells, killer immunoglobulin-like receptors and human leukocyte antigen class I in disease. Clin Exp Immunol 2007; 149:1-8. [PMID: 17521317]
27. Single RM, Martin MP, Meyer D, Gao XJ, Carrington M. Methods for assessing gene diversity of KIR with examples from global set of populations. Immunogenetics 2008; 60:711-25. [PMID: 18797862]
28. Gaafar A, Sheereen A, Iqneibi A, Mohamed G, Al Sulaiman A, Turpeinen H, Al Hussein K. Killer cell immunoglobulin-like receptor gene diversity in the Saudi population. Mol Biol Rep 2011; 38:2603-10. [PMID: 21107733]
29. Namekawa T, Synder MR, Yen JH, Goehring BE, Leibson PJ, Weynand CM, Goronzy JJ. Killer cell activating receptors function as costimulatory molecules on CD4+CD28 null T cells clonally expanded in Rheumatoid Arthritis. J Immunol 2000; 165:1138-45. [PMID: 10878393]
30. Levinson RD, Du Z, Luo L, Holland GN, Rao NA, Reed EF, Rajalingam R. KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease. Hum Immunol 2008; 69:349-53. [PMID: 18571006]
31. Wauquier N, Padilla C, Becquart P, Leroy E, Vieillard V. Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. Immunogenetics 2010; 62:767-71. [PMID: 20878400]